Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Long-term cohort studies

Topic: Brain proteins, microglia and lab models

Cerebrovascular disease is associated with an increased likelihood of developing dementia. Cerebrovascular risk factors are modifiable and may reduce the risk of later-life cognitive dysfunction, however, the relationship between cerebrovascular risk factors, brain integrity and cognition remains poorly characterised. Using a UK Biobank sample of mid-to-old aged adults, without neurological disease, our structural equation mediation models showed that poor cerebrovascular health, indicated by the presence of cerebrovascular risk factors, was associated with slowed processing speed. This effect was best explained by anterior white matter microstructure (e.g. genu, anterior corona radiata), rather than posterior (e.g. splenium, posterior corona radiata)-the mediatory effect of anterior white matter strengthened further with age. Effects were also significantly reduced when considering other forms of cognition, demonstrating both regional- and cognitive-specificity. Our findings also illustrate that cerebrovascular risk factors cross-sectionally predict cognitive processing speed performance, which can be further strengthened by accounting for risk factor duration, particularly hypertensive duration. In summary, our study highlights the vulnerability of anterior regions and sensitivity of processing speed performance to cerebrovascular burden, and show this effect is amplified with age. We also highlight an improved method of cerebrovascular burden quantification, which accounts for factor duration, as well as risk factor presence and degree. Future work will aim to establish the role of medication and effective risk factor control in alleviating or preventing white matter pathology and cognitive dysfunction.

Key findings

Why it matters

In this UK Biobank study, poorer cerebrovascular health was linked to slower processing speed, explained by the microstructure of anterior white matter, with the effect stronger with age. The findings describe how cerebrovascular risk factors relate to cognition and do not test whether modifying them prevents dementia.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 6 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.0 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 3.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Nils Muhlert: h-index 34 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Manchester: institution h-index 1,304 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40119105)
Free to read 2 / 2 Free to read
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Moran, K. L., Smith, C. J., McManus, E., Allan, S. M., Montaldi, D., & Muhlert, N. (2025). Cerebrovascular health impacts processing speed through anterior white matter alterations: a UK biobank study. Scientific Reports. https://doi.org/10.1038/s41598-025-93399-2

Vancouver

Moran KL, Smith CJ, McManus E, Allan SM, Montaldi D, Muhlert N. Cerebrovascular health impacts processing speed through anterior white matter alterations: a UK biobank study. Scientific Reports. 2025. doi:10.1038/s41598-025-93399-2. PMID: 40119105.

BibTeX

@article{moran2025-40119105,
  author  = {Moran, Katie L. and Smith, Craig J. and McManus, Elizabeth and Allan, Stuart McRae and Montaldi, Daniela and Muhlert, Nils},
  title   = {{Cerebrovascular health impacts processing speed through anterior white matter alterations: a UK biobank study}},
  journal = {Scientific Reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-93399-2},
  pmid    = {40119105},
  url     = {https://doi.org/10.1038/s41598-025-93399-2}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Long-term cohort studies

Also tagged “cerebral”

900 studies in the library carry the topic tag “cerebral”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.

Similar studies

More on Long-term cohort studies

See all studies in Long-term cohort studies →